With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response
Ideal for cell and gene therapy and COVID-19 research, BioStore IIIv offers inventory control and reporting capabilities
The modular solution aims to deliver test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources
Exclusive interviews, new methods, free downloads, and much more to help you advance your work
California Laboratories can now instantly transmit covid-19 data to the CalREDIE system
Dr. Nallasivam Palanisamy, Henry Ford Cancer Institute, discusses his discovery of the first pseudogene-associated recurrent gene fusion in cancer and the potential for this robust biomarker for application beyond prostate cancer
Watch this on-demand webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine
Rapid antibody test receives CE mark for use by healthcare professionals
University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery
TrueBinding signs multi-product commercial-use license to develop stable, antibody-expressing cell lines using Horizon’s gene-edited CHO GS knockout platform
87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus
Developed with enhanced technology, this new assay provides high-quality staining with improved turnaround time
New platform provides faster identification of defects that impact device performance
Leading clinical scientists and health professionals have come together to discuss the latest diagnostic and point-of-care solutions at this critical time
The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting
Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe
Find out how LC-MS technology is being used to quantify the experimental drug remdesivir
The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test
